Europese Unie - Nederlands - EMA (European Medicines Agency)

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - immuun-sera en immunoglobulinen, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. zie hoofdstuk 4. 4 en 5.

Europese Unie - Nederlands - EMA (European Medicines Agency)

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - ophthalmologica - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Europese Unie - Nederlands - EMA (European Medicines Agency)

novartis europharm limited - basiliximab - graft rejection; kidney transplantation - immunosuppressiva - simulect is geïndiceerd voor de profylaxe van acute orgaanafstoting bij de novo allogene niertransplantatie bij volwassen en pediatrische patiënten (1-17 jaar). het is om te worden gebruikt samen met ciclosporine voor microemulsion - en corticosteroïd-gebaseerde immunosuppressie, bij patiënten met een panel-reactieve antilichamen minder dan 80%, of een drie-onderhoud immunosuppressief regime met ciclosporine voor microemulsion, corticosteroïden en azathioprine of mycofenolaat mofetil.

Europese Unie - Nederlands - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressiva - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.

Europese Unie - Nederlands - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosuppressiva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dr. fisher farma b.v. - everolimus; - tablet - everolimus

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

bmodesto b.v. - everolimus - tablet - butylhydroxytolueen (e 321) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 0-water ; lactose 1-water ; magnesiumstearaat (e 470b), - everolimus

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

novartis pharma b.v. haaksbergweg 16 1101 bx amsterdam - everolimus - tablet - butylhydroxytolueen (e 321) ; crospovidon (e 1202) ; hypromellose (e 464) ; lactose 0-water ; lactose 1-water ; magnesiumstearaat (e 470b), - everolimus

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

euro registratie collectief b.v. - everolimus - tablet - butylhydroxytolueen (e 321) ; crospovidon (e 1202) ; hypromellose (e 464) ; lactose 0-water ; lactose 1-water ; magnesiumstearaat (e 470b), - everolimus

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

novartis pharma b.v. haaksbergweg 16 1101 bx amsterdam - everolimus - tablet - butylhydroxytolueen (e 321) ; crospovidon (e 1202) ; hypromellose (e 464) ; lactose 0-water ; lactose 1-water ; magnesiumstearaat (e 470b), - everolimus